vs
Side-by-side financial comparison of MEDIFAST INC (MED) and Origin Bancorp, Inc. (OBK). Click either name above to swap in a different company.
Origin Bancorp, Inc. is the larger business by last-quarter revenue ($104.0M vs $75.1M, roughly 1.4× MEDIFAST INC). Over the past eight quarters, Origin Bancorp, Inc.'s revenue compounded faster (3.9% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Southern Bancorp is a community development financial institution headquartered in Arkadelphia, Arkansas. It was founded in 1986 as Southern Development Bancorporation, and is often referred to simply as "Southern".
MED vs OBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $104.0M |
| Net Profit | — | $27.7M |
| Gross Margin | 69.4% | — |
| Operating Margin | -10.4% | — |
| Net Margin | — | 26.6% |
| Revenue YoY | -36.9% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $-1.64 | $0.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $104.0M | ||
| Q4 25 | $75.1M | $103.4M | ||
| Q3 25 | $89.4M | $109.8M | ||
| Q2 25 | $105.6M | $83.5M | ||
| Q1 25 | $115.7M | $94.1M | ||
| Q4 24 | $119.0M | $78.3M | ||
| Q3 24 | $140.2M | $90.8M | ||
| Q2 24 | $168.6M | $96.4M |
| Q1 26 | — | $27.7M | ||
| Q4 25 | — | $29.5M | ||
| Q3 25 | $-2.3M | $8.6M | ||
| Q2 25 | $2.5M | $14.6M | ||
| Q1 25 | $-772.0K | $22.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $1.1M | $18.6M | ||
| Q2 24 | $-8.2M | $21.0M |
| Q1 26 | — | — | ||
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 73.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | -10.4% | 36.2% | ||
| Q3 25 | -4.6% | 10.0% | ||
| Q2 25 | -1.0% | 22.3% | ||
| Q1 25 | -1.1% | 30.4% | ||
| Q4 24 | 0.6% | 23.0% | ||
| Q3 24 | 1.5% | 26.1% | ||
| Q2 24 | -4.7% | 27.7% |
| Q1 26 | — | 26.6% | ||
| Q4 25 | — | 28.5% | ||
| Q3 25 | -2.5% | 7.9% | ||
| Q2 25 | 2.3% | 17.5% | ||
| Q1 25 | -0.7% | 23.8% | ||
| Q4 24 | — | 18.2% | ||
| Q3 24 | 0.8% | 20.5% | ||
| Q2 24 | -4.8% | 21.8% |
| Q1 26 | — | $0.89 | ||
| Q4 25 | $-1.64 | $0.95 | ||
| Q3 25 | $-0.21 | $0.27 | ||
| Q2 25 | $0.22 | $0.47 | ||
| Q1 25 | $-0.07 | $0.71 | ||
| Q4 24 | $0.08 | $0.45 | ||
| Q3 24 | $0.10 | $0.60 | ||
| Q2 24 | $-0.75 | $0.67 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $198.9M | $1.3B |
| Total Assets | $248.0M | $10.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $167.3M | $424.2M | ||
| Q3 25 | $173.5M | $626.9M | ||
| Q2 25 | $162.7M | $334.1M | ||
| Q1 25 | $164.6M | $486.2M | ||
| Q4 24 | $162.3M | $470.2M | ||
| Q3 24 | $170.0M | $321.2M | ||
| Q2 24 | $163.5M | $288.1M |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $198.9M | $1.2B | ||
| Q3 25 | $214.7M | $1.2B | ||
| Q2 25 | $216.0M | $1.2B | ||
| Q1 25 | $211.0M | $1.2B | ||
| Q4 24 | $210.1M | $1.1B | ||
| Q3 24 | $207.3M | $1.1B | ||
| Q2 24 | $205.3M | $1.1B |
| Q1 26 | — | $10.2B | ||
| Q4 25 | $248.0M | $9.7B | ||
| Q3 25 | $268.2M | $9.8B | ||
| Q2 25 | $269.3M | $9.7B | ||
| Q1 25 | $280.0M | $9.8B | ||
| Q4 24 | $284.2M | $9.7B | ||
| Q3 24 | $291.2M | $10.0B | ||
| Q2 24 | $293.5M | $9.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | — |
| Free Cash FlowOCF − Capex | $-6.6M | — |
| FCF MarginFCF / Revenue | -8.8% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-5.3M | $158.9M | ||
| Q3 25 | $12.1M | $59.3M | ||
| Q2 25 | $-3.4M | $20.6M | ||
| Q1 25 | $3.4M | $35.6M | ||
| Q4 24 | $-4.9M | $108.5M | ||
| Q3 24 | $9.1M | $39.6M | ||
| Q2 24 | $13.1M | $11.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.6M | $151.1M | ||
| Q3 25 | $10.8M | $56.8M | ||
| Q2 25 | $-4.8M | $19.6M | ||
| Q1 25 | $1.9M | $34.8M | ||
| Q4 24 | $-7.2M | $86.4M | ||
| Q3 24 | $7.7M | $32.2M | ||
| Q2 24 | $11.1M | $6.5M |
| Q1 26 | — | — | ||
| Q4 25 | -8.8% | 146.0% | ||
| Q3 25 | 12.0% | 51.7% | ||
| Q2 25 | -4.5% | 23.5% | ||
| Q1 25 | 1.6% | 37.0% | ||
| Q4 24 | -6.1% | 110.3% | ||
| Q3 24 | 5.5% | 35.5% | ||
| Q2 24 | 6.6% | 6.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 7.6% | ||
| Q3 25 | 1.5% | 2.3% | ||
| Q2 25 | 1.3% | 1.2% | ||
| Q1 25 | 1.3% | 0.8% | ||
| Q4 24 | 1.9% | 28.1% | ||
| Q3 24 | 1.0% | 8.1% | ||
| Q2 24 | 1.1% | 5.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.38× | ||
| Q3 25 | — | 6.88× | ||
| Q2 25 | -1.36× | 1.41× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 7.60× | ||
| Q3 24 | 8.04× | 2.13× | ||
| Q2 24 | — | 0.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
OBK
| Net Interest Income | $87.2M | 84% |
| Noninterest Income | $16.8M | 16% |
